A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu‐Hui Chen, Raymond H. Mak, Jochen H. Lorch, Glenn J. Hanna, Mizuki Nishino, Claire Manuszak, Emily M. Thrash, Mariano Severgnini, Matthew R. Sanborn, Vishwajith Sridharan, Danielle N. Margalit, Roy B. Tishler, Paul M. Busse, Henning Willers, Harvey J. Mamon, Hyung‐Jin Yoo, Sara I. Pai, Lori J. Wirth, Robert I. Haddad, Nicole G. Chau, Jonathan D. Schoenfeld
Topics & Concepts
Adenoid cystic carcinomaPembrolizumabMedicineOncologyInternal medicineCarcinomaCancerImmunotherapySalivary Gland Tumors Diagnosis and TreatmentColorectal and Anal CarcinomasHead and Neck Surgical Oncology